FDA (Drugs) recall action 63759
The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.
Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Ranbaxy Inc. is recalling specific lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.